Lipid storage myopathy
Lipid storage myopathy (LSM) refers to abnormal lipid deposition in the muscle, which is the main pathological change. This disease is a metabolic myopathy caused by defects in the oxidation of long-chain fatty acids in the muscle, and is a manifestation of a genetic disease of fat metabolism in the nervous system. This disease was first described by Engel et al. in 1973, and Cao Peizhi et al. (1990) first reported two cases in China, and there have been reports from various places since then.
-
Site of disease:
Cranial muscles -
Infectious :
Not contagious -
Frequent population:
child -
Related symptoms:
Symmetrical muscle weakness myalgia proteinuria myasthenia symmetric muscle weakness -
Concurrent disease:
Related Drugs
Pyridostigmine Bromide Tablets
Indication: Used for myasthenia gravis, functional intestinal flatulence and urinary retention after surgery, etc.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Related Ingredients